Skip to content

Development and validation of community salt reduction interventions

Development and validation of community salt reduction interventions based on cluster factorial randomized controlled trials

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102143
Enrollment
Unknown
Registered
2025-05-09
Start date
2025-05-20
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

Group 1:Reduced salt shaker + enhanced tone + low sodium salt
Group 2:Reduced salt shaker + enhanced tone
Group 4:Salt shaker + regular tone
Group 3:Salt shaker + regular tone + low sodium salt
Group 8:regular tone + low sodium salt
Group 7:enhanced tone
Group 6:enhanced tone+low sodium salt
Group 5:regular tone

Sponsors

Guangzhou Center for Disease Control and Prevention
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. It has been included in the management of essential hypertension in community health service centers/township health centers;

Exclusion criteria

Exclusion criteria: 1. During the intervention period, those who could not receive chronic disease services or might interrupt monitoring due to their tendency to live in other places or high mobility were defined as "no longer living in Conghua for 6 months or more due to migrant work, study or relocation"; 2. Patients with chronic kidney disease stage 3 and above, heart failure grade II and above; 3. Pregnant or lactating women; 4. Are using two or more hyperkalemia inducing drugs (such as angiotensin converting (ACEI)/angiotensin II receptor antagonists (ARBs), salocorticoid receptor antagonists (spirenolactone, finelidone), etc.); 5. Hyperkalemia during the intervention terminated the investigator; 6. Access to medical care or the respondent is difficult due to conditions such as intellectual disability, mental impairment, immobility or inability to communicate.

Design outcomes

Primary

MeasureTime frame
24 hours sodium urine;

Secondary

MeasureTime frame
Blood pressure;Salt usage;Blood pressure control rate;Urine potassium 24 hours;The proportion of patients participating in the project to the target population;The cost of implementing the intervention;

Countries

China

Contacts

Public ContactQi Juan

Guangzhou Center for Disease Control and Prevention

651545039@qq.com+86 20 36062333

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026